Biodesix (BDSX) Operating Leases (2022 - 2025)
Historic Operating Leases for Biodesix (BDSX) over the last 4 years, with Q3 2025 value amounting to $24.4 million.
- Biodesix's Operating Leases fell 309.24% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year decrease of 309.24%. This contributed to the annual value of $24.8 million for FY2024, which is 133.13% down from last year.
- Latest data reveals that Biodesix reported Operating Leases of $24.4 million as of Q3 2025, which was down 309.24% from $24.1 million recorded in Q2 2025.
- Over the past 5 years, Biodesix's Operating Leases peaked at $25.5 million during Q2 2024, and registered a low of $1.2 million during Q1 2022.
- Moreover, its 4-year median value for Operating Leases was $24.4 million (2025), whereas its average is $17.8 million.
- Its Operating Leases has fluctuated over the past 5 years, first soared by 92285.47% in 2023, then plummeted by 536.54% in 2025.
- Quarter analysis of 4 years shows Biodesix's Operating Leases stood at $5.3 million in 2022, then skyrocketed by 378.93% to $25.2 million in 2023, then dropped by 1.33% to $24.8 million in 2024, then fell by 1.68% to $24.4 million in 2025.
- Its Operating Leases stands at $24.4 million for Q3 2025, versus $24.1 million for Q2 2025 and $24.5 million for Q1 2025.